Literature DB >> 10566674

Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix.

C A Koch1, N Azumi, M A Furlong, R C Jha, T E Kehoe, C H Trowbridge, T M O'Dorisio, G P Chrousos, S C Clement.   

Abstract

Neuroendocrine tumors of the cervix are rare and are often under- or misdiagnosed. Because these tumors are very aggressive, early diagnosis and subsequent treatment are warranted. We describe a 46-yr-old woman with carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. At age 44, she had dysplasia on Pap smear and underwent total abdominal hysterectomy with the diagnosis of adenocarcinoma. Fourteen months postoperatively, she developed the carcinoid syndrome and was found to have numerous liver metastases. Histological and immunohistochemical investigations of biopsy specimens from the patient's liver lesions and original cervical lesion ("adenocarcinoma") suggested that this woman had a primary atypical carcinoid of the uterine cervix with metastases to the liver. Treatment with octreotide and alkylating agents decreased the episodes of flushing and diarrhea within 8 weeks. If an adenocarcinoma of the uterine cervix is diagnosed, atypical carcinoid should be in the differential diagnosis. Symptoms of the carcinoid syndrome should be pursued and, if present, a urinary 5-hydroxyindolacetic acid level should be obtained. Timely diagnosis of a neuroendocrine tumor of the cervix may improve survival.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566674     DOI: 10.1210/jcem.84.11.6126

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?

Authors:  G I Uwaifo; C A Koch; B Hirshberg; C C Chen; P Hartzband; L K Nieman; K Pacak
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

Review 2.  Echocardiography in functional midgut neuroendocrine tumors: When and how often.

Authors:  Javier G Castillo; Tara Naib; Jerome S Zacks; David H Adams
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 3.  An analysis of rare carcinoid tumors: clarifying these clinical conundrums.

Authors:  Irvin M Modlin; Michael D Shapiro; Mark Kidd
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

Review 4.  Flushing in (neuro)endocrinology.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

5.  Editorial : Neuroendocrine neoplasms.

Authors:  Christian A Koch; Stephan Petersenn
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

6.  Black swans - neuroendocrine tumors of rare locations.

Authors:  Christian A Koch; S Petersenn
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 7.  Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors.

Authors:  Sergio Pedraza-Arévalo; Manuel D Gahete; Emilia Alors-Pérez; Raúl M Luque; Justo P Castaño
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

8.  Neuroendocrine differentiation in a case of cervical cancer.

Authors:  Mona Mohamed Rashed; Alemayehu Bekele
Journal:  Pan Afr Med J       Date:  2010-07-28

9.  Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery.

Authors:  Mathias Fasshauer; Thomas Lincke; Helmut Witzigmann; Regine Kluge; Andrea Tannapfel; Michael Moche; Michael Buchfelder; Stephan Petersenn; Juergen Kratzsch; Ralf Paschke; Christian A Koch
Journal:  BMC Cancer       Date:  2006-04-27       Impact factor: 4.430

10.  Atypical carcinoid of the uterine cervix with aggressive clinical behavior: A case report.

Authors:  Toshiaki Yasuoka; Hisashi Hashimoto; Katsuyuki Hamada; Toru Fujioka; Akihiro Nawa
Journal:  Gynecol Oncol Case Rep       Date:  2013-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.